Skocz do pozycji: 1.

Tytuł:

Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study.

Autorzy:

Castillo-Rozas G; Laboratory of Molecular and Cellular Virology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.
Tu S; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Luz PM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Mejia F; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Sierra-Madero J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Rouzier V; Groupe Haitien d'Etudes du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti.
Shepherd BE; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Cortes CP; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Internal Medicine, Faculty of Medicine, University of Chile, Santiago, Chile.; Hospital Clínico San Borja Arriarán & Fundación Arriarán, Santiago, Chile.; Millenium Institute on Immunology and Immunotherapy, Santiago, Chile.

Pokaż więcej

Źródło:

Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26214.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Retrospective Studies ; Risk Factors ; Drug Therapy, Combination ; CD4 Lymphocyte Count ; Viral Load ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 2.

Tytuł:

Accurate and reproducible enumeration of CD4 T cell counts and Hemoglobin levels using a point of care system: Comparison with conventional laboratory based testing systems in a clinical reference laboratory in Cameroon.

Autorzy:

Sagnia, Bertrand (AUTHOR)
Mbakop Ghomsi, Fabrice (AUTHOR)
Moudourou, Sylvie (AUTHOR)
Gutierez, Ana (AUTHOR)
Tchadji, Jules (AUTHOR)
Sosso, Samuel Martin (AUTHOR)
Ndjolo, Alexis (AUTHOR)
Colizzi, Vittorio (AUTHOR)

Pokaż więcej

Źródło:

PLoS ONE. 3/20/2024, Vol. 19 Issue 3, p1-11. 11p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 3.

Tytuł:

Hospitalisation rates for youth living with perinatally acquired HIV in England.

Autorzy:

Johnson, Sarah May (AUTHOR)
Teh, Jhia Jiat (AUTHOR)
Pasvol, Thomas Joshua (AUTHOR)
Ayres, Sara (AUTHOR)
Lyall, Hermione (AUTHOR)
Fidler, Sarah (AUTHOR)
Foster, Caroline (AUTHOR)

Pokaż więcej

Źródło:

PLoS ONE. 3/19/2024, Vol. 19 Issue 3, p1-9. 9p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 4.

Tytuł:

Predictors of severe hepatotoxicity among retroviral infected adults on HAART regimen in Ilubabor Zone, Southwest Ethiopia.

Autorzy:

Darge T; Department of Biomedical Sciences, College of Health Sciences, Mettu University, Mettu, Ethiopia. .
Babusha A; Department of Biomedical Sciences, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Chilo D; Department of Pharmacy, College of Health Sciences, Mettu University, Mettu, Ethiopia.
Dukessa A; Department of Biomedical Sciences, Institution of Health, Jimma University, Jimma, Ethiopia.
Teferi S; Department of Medical Laboratory Science, College of Health Sciences, Mettu University, Mettu, Ethiopia.

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2024 Apr 11; Vol. 14 (1), pp. 8473. Date of Electronic Publication: 2024 Apr 11.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Coinfection*
Hepatitis C*/drug therapy
Liver Diseases*/etiology
Tuberculosis*/drug therapy
Drug-Related Side Effects and Adverse Reactions*/etiology
Digestive System Diseases*/drug therapy
Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/etiology
Chemical and Drug Induced Liver Injury*/drug therapy
Adult ; Humans ; Antiretroviral Therapy, Highly Active/adverse effects ; Ethiopia/epidemiology ; Cross-Sectional Studies ; HIV ; Hepacivirus ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 5.

Tytuł:

Late presentations and missed opportunities among newly diagnosed HIV patients presenting to a specialty clinic in Lebanon.

Autorzy:

Mahmoud M; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Ballouz T; Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland.
Lahoud C; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Adnan J; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Habib PA; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Saab R; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Farhat H; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Hussein ME; Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Rizk N; Division of Infectious Diseases, Department of Internal Medicine, American University of Beirut Medical Center, Riad El Solh, Beirut, 1107 2020, Lebanon. .

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2024 Apr 09; Vol. 14 (1), pp. 8296. Date of Electronic Publication: 2024 Apr 09.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/diagnosis
HIV Infections*/epidemiology
Acquired Immunodeficiency Syndrome*
Sexual and Gender Minorities*
HIV Seropositivity*
Male ; Adult ; Humans ; Female ; Homosexuality, Male ; HIV ; Retrospective Studies ; Risk Factors ; Lebanon/epidemiology ; Delayed Diagnosis ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 6.

Tytuł:

Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.

Autorzy:

Hashempour A; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Khodadad N; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziaei R; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Rezaei B; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghasabi F; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Falahi S; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Kenarkouhi A; Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Davarpanah MA; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. .; Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .

Pokaż więcej

Źródło:

BMC infectious diseases [BMC Infect Dis] 2024 Mar 28; Vol. 24 (1), pp. 358. Date of Electronic Publication: 2024 Mar 28.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*
Anti-HIV Agents*
Adult ; Humans ; Iran ; Cross-Sectional Studies ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Treatment Failure ; Viral Load ; CD4 Lymphocyte Count ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 7.

Tytuł:

Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.

Autorzy:

Tumwegamire A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Fatch R; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Emenyonu NI; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Lodi S; Boston University School of Public Health, Boston, Massachusetts, United States of America.
Muyindike WR; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.; Mbarara Regional Referral Hospital, Mbarara, Uganda.
Kekibiina A; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Adong J; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Ngabirano C; Global Health Collaborative, Mbarara University of Science and Technology, Mbarara, Uganda.
Beesiga B; Infectious Diseases Research Collaboration, Kampala, Uganda.
Marson K; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Golabi N; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Kamya M; Infectious Diseases Research Collaboration, Kampala, Uganda.
Chamie G; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.
Hahn JA; Division of HIV, Infectious Disease and Global Medicine, University of California San Francisco, San Francisco, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, United States of America.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2024 Mar 20; Vol. 19 (3), pp. e0300508. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).

Typ publikacji:

Journal Article

MeSH Terms:

Alcoholism*/complications
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Adult ; Female ; Cross-Sectional Studies ; Smoking/epidemiology ; Uganda/epidemiology ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Ethanol/therapeutic use ; Viral Load

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 8.

Tytuł:

Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.

Autorzy:

Brazier E; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.; City University of New York, Graduate School of Public Health and Health Policy, New York, New York, United States of America.
Tymejczyk O; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.
Wools-Kaloustian K; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Jiamsakul A; The Kirby Institute, University of New South Wales, Sydney, Australia.
Torres MTL; Department of Pediatrics, Instituto Hondureño de Seguridad Social and Hospital Escuela Universitario, Tegucigalpa, Honduras.
Lee JS; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Abuogi L; Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, United States of America.
Khol V; National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia.
Mejía Cordero F; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
Althoff KN; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Law MG; The Kirby Institute, University of New South Wales, Sydney, Australia.
Nash D; City University of New York, Institute for Implementation Science in Population Health (ISPH), New York, New York, United States of America.; City University of New York, Graduate School of Public Health and Health Policy, New York, New York, United States of America.

Pokaż więcej

Corporate Authors:

International epidemiology Databases to Evaluate AIDS (IeDEA)

Źródło:

PLoS medicine [PLoS Med] 2024 Mar 18; Vol. 21 (3), pp. e1004367. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).

Typ publikacji:

Journal Article

MeSH Terms:

Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Adult ; Female ; Humans ; Male ; CD4 Lymphocyte Count ; Cohort Studies ; Proportional Hazards Models ; Retrospective Studies ; Observation ; Adolescent

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 9.

Tytuł:

Factors influencing rapid antiretroviral therapy initiation in Jiulongpo, Chongqing, China: a retrospective cohort from 2018 to 2022.

Autorzy:

Chen C; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Chen H; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Wu L; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
Gong Q; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China.
He J; Center for Disease Control and Prevention of Jiulongpo Distract, Chongqing, China. .

Pokaż więcej

Źródło:

AIDS research and therapy [AIDS Res Ther] 2024 Mar 17; Vol. 21 (1), pp. 15. Date of Electronic Publication: 2024 Mar 17.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; CD4 Lymphocyte Count ; China/epidemiology ; Proportional Hazards Models

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 10.

Tytuł:

The trajectories of CD4 T lymphocytes over time in patients who have defaulted on treatment for tuberculosis in a cohort of people living with HIV, Recife/PE.

Autorzy:

Cunha R; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Filho DBM; Postgraduate Program in Health Sciences, Universidade de Pernambuco, Recife, Brazil.
M Albuquerque MFP; Aggeu Magalhães Research Center (CPqAM), FIOCRUZ, Recife, Brazil.
Lacerda HR; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Diniz GTN; NEG-Aggeu Magalhães Research Center, Fundação Oswaldo Cruz, Recife, Brazil.
Montarroyos UR; Institute of Biological Sciences, Universidade de Pernambuco, Recife, Brazil.
Rodrigues LC; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Vilela Moura LCR; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.
Ximenes RAA; Postgraduate Program in Tropical Medicine, Universidade Federal de Pernambuco, Recife, Brazil.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2024 Mar 13; Vol. 19 (3), pp. e0299244. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/complications
HIV Infections*/drug therapy
Tuberculosis*/drug therapy
Tuberculosis*/complications
Tuberculosis, Pulmonary*/drug therapy
Tuberculosis, Pulmonary*/complications
Humans ; CD4-Positive T-Lymphocytes ; CD4 Lymphocyte Count ; Anti-Retroviral Agents/therapeutic use

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 11.

Tytuł:

Mortality and associated factors among people living with HIV admitted at a tertiary-care hospital in Uganda: a cross-sectional study.

Autorzy:

Owachi D; Kiruddu National Referral Hospital, Kampala, P.O. BOX 6588, Uganda. .
Akatukunda P; Makerere University Joint AIDS Program, Kampala, Uganda.
Nanyanzi DS; Makerere University Joint AIDS Program, Kampala, Uganda.
Katwesigye R; Makerere University Joint AIDS Program, Kampala, Uganda.
Wanyina S; Makerere University Joint AIDS Program, Kampala, Uganda.
Muddu M; Makerere University Joint AIDS Program, Kampala, Uganda.
Kawuma S; Makerere University Joint AIDS Program, Kampala, Uganda.
Kalema N; Infectious Diseases Institute, Kampala, Uganda.
Kabugo C; Kiruddu National Referral Hospital, Kampala, P.O. BOX 6588, Uganda.
Semitala FC; Makerere University Joint AIDS Program, Kampala, Uganda.; Department of Medicine, Makerere University, Kampala, Uganda.

Pokaż więcej

Źródło:

BMC infectious diseases [BMC Infect Dis] 2024 Feb 22; Vol. 24 (1), pp. 239. Date of Electronic Publication: 2024 Feb 22.

Typ publikacji:

Journal Article

MeSH Terms:

Coinfection*/drug therapy
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Liver Diseases*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Adult ; Male ; Cross-Sectional Studies ; Uganda/epidemiology ; Tertiary Care Centers ; Hospitalization ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 12.

Tytuł:

Disturbances in the IgG Antibody Profile in HIV-Exposed Uninfected Infants Associated with Maternal Factors.

Autorzy:

Camacho-Pacheco RT; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.; Posgrado en Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Hernández-Pineda J; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Brito-Pérez Y; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Plazola-Camacho N; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Coronado-Zarco IA; Neonatology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Arreola-Ramírez G; Neonatology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Bermejo-Haro MY; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.; Posgrado en Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Najera-Hernández MA; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
González-Pérez G; Department of Physiology and Cellular Development, National Institute of Perinatology (INPer), Mexico City, Mexico.
Herrera-Salazar A; Unidad de Investigación Multidisciplinaria, Facultad de Estudios Superiores Cuautitlán, UNAM, Cuautitlán Izcalli, Mexico.
Olmos-Ortiz A; Immunobiochemistry Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Soriano-Becerril D; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Sandoval-Montes C; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Figueroa-Damian R; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.
Rodríguez-Martínez S; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Ciudad de México, Mexico.
Mancilla-Herrera I; Infectology and Immunology Department, National Institute of Perinatology (INPer), Mexico City, Mexico.

Pokaż więcej

Źródło:

Journal of immunology research [J Immunol Res] 2024 Feb 12; Vol. 2024, pp. 8815767. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*
Infant ; Humans ; Infant, Newborn ; Immunoglobulin G ; Incidence ; CD4 Lymphocyte Count ; Infectious Disease Transmission, Vertical

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 13.

Tytuł:

Dolutegravir based therapy showed CD4 T cell count recovery and viral load suppression among ART naïve people living with HIV AIDS: a pilot evaluation.

Autorzy:

Gebremedhin T; University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia.
Aynalem M; Department of Hematology and Immunohematology, University of Gondar, Gondar, Ethiopia.
Adem M; Department of Immunology and Molecular Biology, University of Gondar, Gondar, Ethiopia.
Geremew D; Department of Medical Laboratory Sciences, Immunology and Molecular Biology Unit, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Aleka Y; Department of Immunology and Molecular Biology, University of Gondar, Gondar, Ethiopia. .
Kiflie A; Department of Immunology and Molecular Biology, University of Gondar, Gondar, Ethiopia.

Pokaż więcej

Źródło:

Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3297. Date of Electronic Publication: 2024 Feb 08.

Typ publikacji:

Journal Article

MeSH Terms:

Acquired Immunodeficiency Syndrome*/drug therapy
HIV Infections*
Anti-HIV Agents*/pharmacology
HIV-1*/genetics
Heterocyclic Compounds, 3-Ring*
Oxazines*
Piperazines*
Pyridones*
Humans ; Antiretroviral Therapy, Highly Active ; Prospective Studies ; Viral Load ; Pilot Projects ; CD4 Lymphocyte Count ; CD4-Positive T-Lymphocytes ; RNA/pharmacology

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 14.

Tytuł:

Factors associated with immunological non-response after ART initiation: a retrospective observational cohort study.

Autorzy:

Zhao, Heping (AUTHOR)
Feng, Anping (AUTHOR)
Luo, Dan (AUTHOR)
Yuan, Tanwei (AUTHOR)
Lin, Yi-Fan (AUTHOR)
Ling, Xuemei (AUTHOR)
Zhong, Huolin (AUTHOR)
Li, Junbin (AUTHOR)
Li, Linghua (AUTHOR)
Zou, Huachun (AUTHOR)

Pokaż więcej

Źródło:

BMC Infectious Diseases. 1/29/2024, Vol. 24 Issue 1, p1-9. 9p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 15.

Tytuł:

Prevalence of vitamin D deficiency in PLHIV and its relation to CD4 count and ART: A cross sectional study.

Autorzy:

Verma, Himeshwari
Lakra, Devpriya
Agarwal, Vyom

Pokaż więcej

Źródło:

Al Ameen Journal of Medical Sciences. Jan-Mar2024, Vol. 17 Issue 1, p90-95. 6p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 16.

Tytuł:

Predictors for CD4 cell count and hemoglobin level with survival time to default for HIV positive adults under ART treatment at University of Gondar Comprehensive and Specialized Hospital, Ethiopia.

Autorzy:

Muhie, Nurye Seid (AUTHOR)
Tegegne, Awoke Seyoum (AUTHOR)

Pokaż więcej

Źródło:

BMC Research Notes. 12/2/2023, Vol. 16 Issue 1, p1-11. 11p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 17.

Tytuł:

Outcomes of antiretroviral treatment for 0-14-year-old children living with HIV in Ganzhou, China, 2006-2023.

Autorzy:

Zeng T; Department of Pathogenic Biology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou, China.
Chen X; Department of Pathogenic Biology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou, China.
Zhang XY; Department of Epidemiology, School of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Lian CX; Department of Epidemiology, School of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Yang RR; Department of AIDS/STD Control and Prevention, Ganzhou Center for Disease Control and Prevention, No. 6 Zhangjiangbei Avenue, Zhanggong District, Ganzhou, 341000, China.
Yu LL; Department of AIDS/STD Control and Prevention, Ganzhou Center for Disease Control and Prevention, No. 6 Zhangjiangbei Avenue, Zhanggong District, Ganzhou, 341000, China.
Liao XK; Department of AIDS/STD Control and Prevention, Ganzhou Center for Disease Control and Prevention, No. 6 Zhangjiangbei Avenue, Zhanggong District, Ganzhou, 341000, China.
Huang DD; Department of Pathogenic Biology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou, China.
Zhang YN; Department of Pathogenic Biology, School of Basic Medical Sciences, Gannan Medical University, Ganzhou, China.
Cao HM; Department of AIDS/STD Control and Prevention, Ganzhou Center for Disease Control and Prevention, No. 6 Zhangjiangbei Avenue, Zhanggong District, Ganzhou, 341000, China. .

Pokaż więcej

Źródło:

AIDS research and therapy [AIDS Res Ther] 2024 Jan 31; Vol. 21 (1), pp. 8. Date of Electronic Publication: 2024 Jan 31.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Child ; Humans ; Infant, Newborn ; Infant ; Child, Preschool ; Adolescent ; Retrospective Studies ; Anti-Retroviral Agents/therapeutic use ; Disease Progression ; CD4 Lymphocyte Count ; China/epidemiology ; Viral Load

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 18.

Tytuł:

Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV.

Autorzy:

Chen C; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China.
Wang J; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China.
Xun J; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China.
Zhang X; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China.
Liu L; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China.
Song Z; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China.
Zhang R; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China.
Chen J; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China. .
Lu H; Shanghai Public Health Clinical Center, Fudan University, Caolang Road 2901, Jinshan, Shanghai, 201508, China. .; National Clinical Research Centre for Infectious Diseases, The Third People' s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, 518112, China. .

Pokaż więcej

Źródło:

BMC infectious diseases [BMC Infect Dis] 2024 Jan 17; Vol. 24 (1), pp. 97. Date of Electronic Publication: 2024 Jan 17.

Typ publikacji:

Journal Article

MeSH Terms:

Hepatitis A Virus Cellular Receptor 2*
HIV Infections*/drug therapy
Humans ; Male ; Female ; Adult ; Middle Aged ; Thymalfasin/therapeutic use ; Programmed Cell Death 1 Receptor ; Prospective Studies ; CD4-Positive T-Lymphocytes ; CD4 Lymphocyte Count ; Immunity

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 19.

Tytuł:

Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.

Autorzy:

Gils T; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Global Health Institute, University of Antwerp, Wilrijk, Belgium.
Kamele M; SolidarMed, Partnerships for Health, Butha-Buthe, Lesotho.
Madonsela T; Centre for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.
Bosman S; Centre for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.
Ngubane T; Centre for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.
Joseph P; Centre for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.
Reither K; Clinical Research Unit, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Medical Outpatient Department, University of Basel, Basel, Switzerland.
Bresser M; Clinical Research Unit, Swiss Tropical and Public Health Institute, Allschwil, Switzerland.; Medical Outpatient Department, University of Basel, Basel, Switzerland.
Vlieghe E; Global Health Institute, University of Antwerp, Wilrijk, Belgium.
Decroo T; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Ayakaka I; SolidarMed, Partnerships for Health, Butha-Buthe, Lesotho.
Lynen L; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Van Heerden A; Centre for Community Based Research, Human Sciences Research Council, Pietermaritzburg, South Africa.; MRC/Wits Developmental Pathways for Health Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 Dec 22; Vol. 18 (12), pp. e0296197. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

Tuberculosis*/diagnosis
Tuberculosis*/complications
HIV Infections*/complications
HIV Infections*/diagnosis
Adult ; Humans ; Point-of-Care Systems ; CD4 Lymphocyte Count ; Point-of-Care Testing ; Sensitivity and Specificity

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 20.

Tytuł:

Characteristics of blood immune cell profile and their correlation with disease progression in patients infected with HIV-1.

Autorzy:

Guo XY; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Qu MM; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Wang X; Clinic of Center for Infection, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Wang ZR; Department of Gastroenterology, First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.
Song JW; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Yang BP; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Guo YT; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Zhang Y; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Zhang C; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Fan X; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Xu W; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Xu R; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Zhang JY; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Chen SY; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Jiao YM; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China. .
Sun LJ; Clinic of Center for Infection, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. .
Wang FS; Senior Department of Infectious Diseases, The Fifth Medical Centre of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China. .

Pokaż więcej

Źródło:

BMC infectious diseases [BMC Infect Dis] 2023 Dec 20; Vol. 23 (1), pp. 893. Date of Electronic Publication: 2023 Dec 20.

Typ publikacji:

Journal Article

MeSH Terms:

HIV-1*
HIV Infections*
Humans ; CD8-Positive T-Lymphocytes ; RNA ; Disease Progression ; DNA ; CD4-Positive T-Lymphocytes ; Viral Load ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 21.

Tytuł:

Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studies.

Autorzy:

Trickey A; Population Health Sciences, University of Bristol, Bristol, UK. .
Johnson LF; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Fung F; Department of Civil Engineering, University of Bristol, Bristol, UK.; UK Meteorological Office, Exeter, UK.
Bonifacio R; Climate and Earth Observation Unit, Research Assessment and Monitoring Division, World Food Programme HQ, Rome, Italy.
Iwuji C; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Department of Global Health Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
Biraro S; ICAP at Columbia University, Nakasero, Kampala, Uganda.
Bosomprah S; Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.; Department of Biostatistics, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Chirimuta L; Newlands Clinic, Harare, Zimbabwe.
Euvrard J; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Fatti G; Kheth'Impilo AIDS Free Living, Cape Town, South Africa.; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Fox MP; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Global Health and Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Von Groote P; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Gumulira J; Lighthouse Trust, Mzimba, Malawi.
Howard G; Department of Civil Engineering and Cabot Institute of the Environment, University of Bristol, Bristol, UK.
Jennings L; Desmond Tutu Health Foundation, Institute of Infectious Diseases and Molecular Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Kiragga A; Research Division, African Population and Health Research Center, Nairobi, Kenya.
Muula G; Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Tanser F; Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.; School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Wagener T; Institute of Environmental Science and Geography, University of Potsdam, Potsdam, Germany.
Low A; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Vickerman P; Population Health Sciences, University of Bristol, Bristol, UK.; NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, Bristol, UK.

Pokaż więcej

Źródło:

BMC infectious diseases [BMC Infect Dis] 2023 Dec 19; Vol. 23 (1), pp. 889. Date of Electronic Publication: 2023 Dec 19.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/complications
Anti-HIV Agents*/therapeutic use
Adult ; Humans ; Female ; Male ; CD4 Lymphocyte Count ; Africa, Southern/epidemiology ; Cohort Studies ; South Africa

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 22.

Tytuł:

HIV transmission and associated factors under the scale-up of HIV antiretroviral therapy: a population-based longitudinal molecular network study.

Autorzy:

Chen Y; The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, Nanning, 530021, China.
Cao Z; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China.
Li J; Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, 530028, China.
Chen J; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China.
Zhu Q; Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, 530028, China.
Liang S; Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, 530028, China.
Lan G; Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, 530028, China.
Xing H; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China.
Liao L; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China.
Feng Y; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China.
Shao Y; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China.
Ruan Y; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China. .
Chen H; Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, 530028, China. .

Pokaż więcej

Źródło:

Virology journal [Virol J] 2023 Dec 04; Vol. 20 (1), pp. 289. Date of Electronic Publication: 2023 Dec 04.

Typ publikacji:

Journal Article

MeSH Terms:

HIV-1*/genetics
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Infectious Disease Transmission, Vertical/prevention & control ; Viral Load

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 23.

Tytuł:

Ocular manifestations in HIV patients attending a tertiary care hospital in Eastern India and correlation of posterior segment lesions with CD4+ counts.

Autorzy:

Swain J; Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan (Deemed to be) University, 8-Kalinga Nagar, Bhubaneswar, Odisha, India.
Sharma PK; Department of Ophthalmology, Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR), Pg chowk, Burla, Odisha, India.
Mohanty L; Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan (Deemed to be) University, 8-Kalinga Nagar, Bhubaneswar, Odisha, India.
Panigrahi PK; Department of Ophthalmology, Institute of Medical Sciences and SUM Hospital, Siksha O Anusandhan (Deemed to be) University, 8-Kalinga Nagar, Bhubaneswar, Odisha, India.

Pokaż więcej

Źródło:

Indian journal of ophthalmology [Indian J Ophthalmol] 2023 Dec 01; Vol. 71 (12), pp. 3701-3706. Date of Electronic Publication: 2023 Nov 20.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/complications
HIV Infections*/diagnosis
HIV Infections*/epidemiology
HIV Seropositivity*/complications
Humans ; Adult ; Young Adult ; Middle Aged ; HIV ; Tertiary Care Centers ; Cross-Sectional Studies ; India/epidemiology ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 24.

Tytuł:

Clinical, molecular, and histological characteristics of severely necrotic and fatal mpox in HIV-infected patients.

Autorzy:

Rajme-López S; Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición, 'Salvador Zubirán' Vasco de Quiroga #15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Corral-Herrera EA; Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición, 'Salvador Zubirán' Vasco de Quiroga #15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Tello-Mercado AC; Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición, 'Salvador Zubirán' Vasco de Quiroga #15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Tepo-Ponce KM; Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición, 'Salvador Zubirán' Vasco de Quiroga #15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Pérez-Meléndez RE; Internal Medicine Department, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
Rosales-Sotomayor Á; Dermatology Department, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
Figueroa-Ramos G; Dermatology Department, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
López-López K; Dermatology Department, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
Domínguez-Cherit JG; Dermatology Department, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
San-Martín-Morante O; Pathology Department, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
Saeb-Lima M; Pathology Department, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
Gamboa-Domínguez A; Pathology Department, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
Ponce-de-León A; Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición, 'Salvador Zubirán' Vasco de Quiroga #15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Crabtree-Ramírez B; Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición, 'Salvador Zubirán' Vasco de Quiroga #15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México, 14080, México.
Ramos-Cervantes P; Virology and Molecular Biology Laboratory, Instituto Nacional de Ciencias Médicas y Nutrición 'Salvador Zubirán', Mexico City, Mexico.
Ruíz-Palacios GM; Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición, 'Salvador Zubirán' Vasco de Quiroga #15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México, 14080, México. .

Pokaż więcej

Źródło:

AIDS research and therapy [AIDS Res Ther] 2023 Nov 27; Vol. 20 (1), pp. 85. Date of Electronic Publication: 2023 Nov 27.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/complications
HIV Infections*/drug therapy
Mpox (monkeypox)*/complications
Mpox (monkeypox)*/drug therapy
Humans ; Male ; Adult ; Female ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Necrosis/chemically induced ; Necrosis/complications ; Necrosis/drug therapy

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 25.

Tytuł:

An evaluation of Mp1p antigen screening for talaromycosis in HIV-infected antiretroviral therapy-naïve population in Guangdong, China.

Autorzy:

Gong D; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Lin W; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Zhang H; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Ou X; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Li L; Research Institute, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Guo P; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
He Y; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Liu C; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Cai W; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Tang X; Research Institute, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Li L; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.

Pokaż więcej

Źródło:

PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Nov 27; Vol. 17 (11), pp. e0011785. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

Mycoses*/diagnosis
HIV Infections*/complications
HIV Infections*/drug therapy
Adult ; Humans ; HIV ; Cross-Sectional Studies ; CD4 Lymphocyte Count

SCR Disease Name:

talaromycosis

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 26.

Tytuł:

Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.

Autorzy:

Mbatia RJ; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Mtisi EL; Department of General Studies, Dar es Salaam Institute of Technology, Dar es Salaam, Tanzania.
Ismail A; US Center for Disease Control and Prevention (CDC), Tanzania Country Office, Dar es Salaam, Tanzania.
Henjewele CV; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Moshi SJ; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Christopher AK; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Nsanzugwanko NW; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Bukuku AG; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Msimbe RA; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Kirato AR; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Nyabukene FS; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Mmari EJ; US Center for Disease Control and Prevention (CDC), Tanzania Country Office, Dar es Salaam, Tanzania.
Rwebembera AA; Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, Tanzania.
Masanja BN; Tanzania Health Promotion Support (THPS), Dar es Salaam, Tanzania.
Kailembo A; US Center for Disease Control and Prevention (CDC), Tanzania Country Office, Dar es Salaam, Tanzania.
Matiko EJ; US Center for Disease Control and Prevention (CDC), Tanzania Country Office, Dar es Salaam, Tanzania.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 Nov 15; Vol. 18 (11), pp. e0292740. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Male ; Adult ; Humans ; Tanzania/epidemiology ; Cross-Sectional Studies ; World Health Organization ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 27.

Tytuł:

Antiretroviral therapy programme outcomes at Senkatana antiretroviral therapy clinic, Lesotho: a four-year retrospective cohort study.

Autorzy:

Kabuya M; Senkatana Antiretroviral Therapy (ART) Clinic Maseru, Maseru, Lesotho.; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Musekiwa A; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Takuva S; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Thabane L; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.; Biostatistics Unit, Father Sean O´Sullivan Research Centre, St Joseph´s Healthcare Hamilton, Hamilton, Ontario, Canada.
Mbuagbaw L; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.; Biostatistics Unit, Father Sean O´Sullivan Research Centre, St Joseph´s Healthcare Hamilton, Hamilton, Ontario, Canada.

Pokaż więcej

Źródło:

The Pan African medical journal [Pan Afr Med J] 2023 Nov 02; Vol. 46, pp. 74. Date of Electronic Publication: 2023 Nov 02 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Humans ; Male ; Female ; Retrospective Studies ; Lesotho/epidemiology ; Anti-Retroviral Agents/therapeutic use ; HIV ; CD4 Lymphocyte Count ; Viral Load

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 28.

Tytuł:

Recent advances in HIV diagnostics: Point-of-care CD4 + T-cell count & viral load assays.

Autorzy:

Balakrishnan P; Centre for Infectious Diseases, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
Saravanan S; Centre for Infectious Diseases, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
Vignesh R; Pre-Clinical Department, Faculty of Medicine, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Malaysia.
Shankar EM; Infection & Inflammation, Department of Biotechnology, Central University of Tamil Nadu, Thiruvarur, Tamil Nadu, India.

Pokaż więcej

Źródło:

The Indian journal of medical research [Indian J Med Res] 2023 Nov 01; Vol. 158 (5&6), pp. 447-450. Date of Electronic Publication: 2024 Jan 24.

Typ publikacji:

Journal Article

MeSH Terms:

Point-of-Care Systems*
HIV Infections*
Humans ; Viral Load ; CD4-Positive T-Lymphocytes ; Lymphocyte Count ; CD4 Lymphocyte Count ; RNA, Viral

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 29.

Tytuł:

A Study of Correlation of Quantitative C–Reactive Protein With CD4 Count in Patients of HIV on ART at KIMS, Hubli, Karnataka.

Autorzy:

Kumar, Anil
Potkar, Shravankumar
K., Pavithra

Pokaż więcej

Źródło:

European Journal of Cardiovascular Medicine. 2023, Vol. 13 Issue 4, p1509-1519. 11p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 30.

Tytuł:

Prevalence and trends of advanced HIV disease among antiretroviral therapy-naïve and antiretroviral therapy-experienced patients in South Africa between 2010-2021: a systematic review and meta-analysis.

Autorzy:

Kitenge, Marcel K. (AUTHOR)
Fatti, Geoffrey (AUTHOR)
Eshun-Wilson, Ingrid (AUTHOR)
Aluko, Omololu (AUTHOR)
Nyasulu, Peter (AUTHOR)

Pokaż więcej

Źródło:

BMC Infectious Diseases. 8/22/2023, Vol. 23 Issue 1, p1-16. 16p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 31.

Tytuł:

Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis.

Autorzy:

Wu, Xinsheng (AUTHOR)
Wu, Guohui (AUTHOR)
Ma, Ping (AUTHOR)
Wang, Rugang (AUTHOR)
Li, Linghua (AUTHOR)
Sun, Yinghui (AUTHOR)
Xu, Junjie (AUTHOR)
Li, Yuwei (AUTHOR)
Zhang, Tong (AUTHOR)
Li, Quanmin (AUTHOR)
Yang, Yuecheng (AUTHOR)
Wang, Lijing (AUTHOR)
Xin, Xiaoli (AUTHOR)
Qiao, Ying (AUTHOR)
Fang, Bingxue (AUTHOR)
Lu, Zhen (AUTHOR)
Zhou, Xinyi (AUTHOR)
Chen, Yuanyi (AUTHOR)
Liu, Qi (AUTHOR)
Fu, Gengfeng (AUTHOR)

Pokaż więcej

Źródło:

Infectious Diseases of Poverty. 8/14/2023, Vol. 12 Issue 1, p1-14. 14p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 32.

Tytuł:

Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review.

Autorzy:

SeyedAlinaghi S; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Afsahi AM; Department of Radiology, School of Medicine, University of California, San Diego (UCSD), San Diego, CA, USA.
Moradi A; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Parmoon Z; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Habibi P; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Mirzapour P; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Dashti M; Department of Radiology, Tabriz University of Medical Sciences, Tabriz, Iran.
Ghasemzadeh A; Department of Radiology, Tabriz University of Medical Sciences, Tabriz, Iran.
Karimi E; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Sanaati F; School of Nursing and Allied Medical Sciences, Maragheh University of Medical Sciences, Maragheh, Iran.
Hamedi Z; Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Molla A; School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Mehraeen E; Department of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, 5681761351, Iran. .
Dadras O; Bergen Addiction Research, Department of Addiction Medicine, Haukland University Hospital, Bergen, Norway.

Pokaż więcej

Źródło:

AIDS research and therapy [AIDS Res Ther] 2023 Oct 27; Vol. 20 (1), pp. 74. Date of Electronic Publication: 2023 Oct 27.

Typ publikacji:

Journal Article; Review

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV-1*
Humans ; CD4 Lymphocyte Count ; Treatment Outcome ; CD4-Positive T-Lymphocytes ; Treatment Failure ; Viral Load

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 33.

Tytuł:

Prevalence of delayed antiretroviral therapy initiation among people living with HIV: A systematic review and meta-analysis.

Autorzy:

Tao Y; Xiangya Nursing School, Central South University, Changsha, Hunan Province, People's Republic of China.
Xiao X; Xiangya Nursing School, Central South University, Changsha, Hunan Province, People's Republic of China.
Zhang C; Xiangya Nursing School, Central South University, Changsha, Hunan Province, People's Republic of China.
Xie Y; Xiangya Nursing School, Central South University, Changsha, Hunan Province, People's Republic of China.
Wang H; Xiangya Nursing School, Central South University, Changsha, Hunan Province, People's Republic of China.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 Oct 24; Vol. 18 (10), pp. e0286476. Date of Electronic Publication: 2023 Oct 24 (Print Publication: 2023).

Typ publikacji:

Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review

MeSH Terms:

Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Adult ; Female ; Humans ; Male ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Prevalence

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 34.

Tytuł:

Rapid antiretroviral therapy initiation in patients with advanced HIV disease: 6-month outcomes of an observational cohort evaluation in Lesotho.

Autorzy:

Tiam A; Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia, United States of America.
Paulin H; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Machekano R; Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia, United States of America.
Oboho I; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Agyemang E; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Mugyenyi FA; Centers for Disease Control and Prevention, Maseru, Lesotho.
Maama-Maime L; Ministry of Health Lesotho, Maseru, Lesotho.
Mengistu Y; Centers for Disease Control and Prevention, Maseru, Lesotho.
Chatora T; Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.
Mungati M; Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.
Mokone M; Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.
Mots'oane T; Ministry of Health Lesotho, Maseru, Lesotho.
Masheane A; Ministry of Health Lesotho, Maseru, Lesotho.
Tukei V; Elizabeth Glaser Pediatric AIDS Foundation, Maseru, Lesotho.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 Oct 11; Vol. 18 (10), pp. e0292660. Date of Electronic Publication: 2023 Oct 11 (Print Publication: 2023).

Typ publikacji:

Observational Study; Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/epidemiology
Adult ; Male ; Adolescent ; Humans ; Female ; Lesotho/epidemiology ; Hospitals ; Patients ; Health Facilities ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 35.

Tytuł:

Retention in Care and Virological Failure among Adult HIV-Positive Patients on First-Line Antiretroviral Treatment in Maputo, Mozambique.

Autorzy:

Joaquim L; Centro Integrado de Cuidados e Tratamento, Hospital Militar de Maputo, Maputo P.O. Box 21414368/9, Mozambique.
Miranda MNS; Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal.
Pimentel V; Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal.
Martins MDRO; Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal.
Nhampossa T; Centro de Investigação em Saúde de Manhiça, Sede, Manhiça, Rua 12, Maputo 1929, Mozambique.
Abecasis A; Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal.
Pingarilho M; Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL), Rua da Junqueira 100, 1349-008 Lisboa, Portugal.

Pokaż więcej

Źródło:

Viruses [Viruses] 2023 Sep 22; Vol. 15 (10). Date of Electronic Publication: 2023 Sep 22.

Typ publikacji:

Observational Study; Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/epidemiology
Retention in Care*
Anti-HIV Agents*/therapeutic use
Humans ; Adult ; Middle Aged ; Mozambique/epidemiology ; Cross-Sectional Studies ; Anti-Retroviral Agents/therapeutic use ; Treatment Failure ; CD4 Lymphocyte Count ; Viral Load

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 36.

Tytuł:

Barriers and facilitators to implementing advanced HIV disease screening at a secondary referral hospital -Malawi: a convergent parallel study.

Autorzy:

Mithi B; Department of Public Health, School of Global and Public Health, Kamuzu University of Health Sciences (KUHeS), P/Bag 360, Chichiri, Blantyre 3, Malawi. .
Bula A; University of North Carolina (UNC) Project, Lilongwe, Malawi.
Kapanda L; Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Lilongwe, Malawi.
Ngwalangwa F; Department of Public Health, School of Global and Public Health, Kamuzu University of Health Sciences (KUHeS), P/Bag 360, Chichiri, Blantyre 3, Malawi.
Sambala EZ; Department of Public Health, School of Global and Public Health, Kamuzu University of Health Sciences (KUHeS), P/Bag 360, Chichiri, Blantyre 3, Malawi.

Pokaż więcej

Źródło:

BMC health services research [BMC Health Serv Res] 2023 Sep 20; Vol. 23 (1), pp. 1015. Date of Electronic Publication: 2023 Sep 20.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/diagnosis
Acquired Immunodeficiency Syndrome*
Humans ; Malawi/epidemiology ; Secondary Care Centers ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 37.

Tytuł:

Enhancing linkage to HIV care in the "Universal Test and Treat" era: Barriers and enablers to HIV care among adults in a high HIV burdened district in KwaZulu-Natal, South Africa.

Autorzy:

Nicol E; Burden of Disease Research Unit, South African Medical Research Council, P.O. Box 19070, TygerbergCape Town, 7505, South Africa. .; Division of Health Systems and Public Health, Stellenbosch University, Cape Town, South Africa. .
Jama NA; Burden of Disease Research Unit, South African Medical Research Council, P.O. Box 19070, TygerbergCape Town, 7505, South Africa.; School of Public Health, University of the Western Cape, Bellville, South Africa.
Mehlomakulu V; Burden of Disease Research Unit, South African Medical Research Council, P.O. Box 19070, TygerbergCape Town, 7505, South Africa.
Hlongwa M; Burden of Disease Research Unit, South African Medical Research Council, P.O. Box 19070, TygerbergCape Town, 7505, South Africa.; School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.; Public Health, Societies and Belonging, Human Sciences Research Council, Pretoria, South Africa.
Pass D; Burden of Disease Research Unit, South African Medical Research Council, P.O. Box 19070, TygerbergCape Town, 7505, South Africa.
Basera W; Burden of Disease Research Unit, South African Medical Research Council, P.O. Box 19070, TygerbergCape Town, 7505, South Africa.; School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Bradshaw D; Burden of Disease Research Unit, South African Medical Research Council, P.O. Box 19070, TygerbergCape Town, 7505, South Africa.; School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Pokaż więcej

Źródło:

BMC public health [BMC Public Health] 2023 Sep 09; Vol. 23 (1), pp. 1756. Date of Electronic Publication: 2023 Sep 09.

Typ publikacji:

Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

MeSH Terms:

Ambulatory Care Facilities*
Economic Factors*
Humans ; Adult ; South Africa ; CD4 Lymphocyte Count ; Fear

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 38.

Tytuł:

Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial.

Autorzy:

Dumchev, Kostyantyn (AUTHOR)
Guo, Xu (AUTHOR)
Ha, Tran Viet (AUTHOR)
Djoerban, Zubairi (AUTHOR)
Zeziulin, Oleksandr (AUTHOR)
Go, Vivian F. (AUTHOR)
Sarasvita, Riza (AUTHOR)
Metzger, David S. (AUTHOR)
Latkin, Carl A. (AUTHOR)
Rose, Scott M. (AUTHOR)
Piwowar-Manning, Estelle (AUTHOR)
Richardson, Paul (AUTHOR)
Hanscom, Brett (AUTHOR)
Lancaster, Kathryn E. (AUTHOR)
Miller, William C. (AUTHOR)
Hoffman, Irving F. (AUTHOR)

Pokaż więcej

Źródło:

BMC Infectious Diseases. 5/11/2023, Vol. 23 Issue 1, p1-15. 15p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 39.

Tytuł:

Antiretroviral Treatment-Induced Galectin-9 Might Impact HIV Viremia in Addition to Contributing to Inflammaging.

Autorzy:

Shete A; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Wagh V; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Sawant J; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Shidhaye P; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Sane S; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Rao A; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Kulkarni S; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.
Ghate M; Indian Council of Medical Research, National AIDS Research Institute (ICMR-NARI), Pune 411026, India.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 Jul 31; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 31.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Antiretroviral Therapy, Highly Active ; Viremia/drug therapy ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Viral Load

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 40.

Tytuł:

Distribution pattern and prevalence of opportunistic infections and their possible reciprocal effects among HIV patients, Burayu health centers, Ethiopia.

Autorzy:

Birmeka M; Department of Biology, Hawassa University, Hawassa, Ethiopia.

Pokaż więcej

Źródło:

Journal of infection in developing countries [J Infect Dev Ctries] 2023 Jul 27; Vol. 17 (7), pp. 1022-1029. Date of Electronic Publication: 2023 Jul 27.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/complications
HIV Infections*/epidemiology
HIV Infections*/drug therapy
Coinfection*/epidemiology
Coinfection*/complications
Opportunistic Infections*/epidemiology
Humans ; Retrospective Studies ; Ethiopia/epidemiology ; Prevalence ; Cross-Sectional Studies ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 41.

Tytuł:

Diabetes in a hospital cohort of persons living with HIV: a descriptive and comparative study in French Guiana.

Autorzy:

Nacher M; CIC INSERM 1424, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana. .; DFR Santé, Université de Guyane, Cayenne, 97300, French Guiana. .; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana. .
Rabier S; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Lucarelli A; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Hureau L; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Adenis A; CIC INSERM 1424, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.; DFR Santé, Université de Guyane, Cayenne, 97300, French Guiana.; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Hafsi N; Service d'endocrinologie diabétologie, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Sabbah N; Service d'endocrinologie diabétologie, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.

Pokaż więcej

Źródło:

BMC infectious diseases [BMC Infect Dis] 2023 Jul 13; Vol. 23 (1), pp. 470. Date of Electronic Publication: 2023 Jul 13.

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/drug therapy
HIV Seropositivity*/drug therapy
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Female ; French Guiana/epidemiology ; CD4 Lymphocyte Count ; Viral Load ; Hospitals

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 42.

Tytuł:

Endothelial Glycocalyx Integrity in Treatment-Naïve People Living with HIV before and One Year after Antiretroviral Treatment Initiation.

Autorzy:

Fragkou PC; First Department of Critical Care and Pulmonary Services, Evangelismos Hospital, Athens Medical School, National and Kapodistrian University of Athens, 10676 Athens, Greece.
Ikonomidis I; Second Department of Cardiology, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Benas D; Second Department of Cardiology, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Kavatha D; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Moschopoulos CD; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Protopapas K; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Kostelli G; Second Department of Cardiology, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Thymis J; Second Department of Cardiology, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Mpirmpa D; Second Department of Cardiology, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Galani I; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Tsakona M; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Oikonomopoulou C; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Theocharous G; Molecular Carcinogenesis Group, Department of Histology and Embryology, Athens Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Gorgoulis VG; Molecular Carcinogenesis Group, Department of Histology and Embryology, Athens Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Gallos P; Computational Biomedicine Laboratory, Department of Digital Systems, University of Piraeus, 18536 Piraeus, Greece.
Tsiodras S; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Antoniadou A; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Papadopoulos A; Fourth Department of Internal Medicine, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Triantafyllidi H; Second Department of Cardiology, Attikon University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Pokaż więcej

Źródło:

Viruses [Viruses] 2023 Jul 05; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 05.

Typ publikacji:

Journal Article; Observational Study; Research Support, Non-U.S. Gov't

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/pathology
Glycocalyx*/drug effects
Glycocalyx*/pathology
Endothelium*/drug effects
Endothelium*/pathology
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Female ; Adult ; Middle Aged ; Cohort Studies ; CD4 Lymphocyte Count ; Viral Load ; Smoking

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 43.

Tytuł:

Advanced HIV disease and associated attrition after re-engagement in HIV care in Myanmar from 2003 to 2019: a retrospective cohort study.

Autorzy:

Mesic A; Médecins Sans Frontières, Public Health Department, Plantage Middenlaan 14, 1001DD, Amsterdam, The Netherlands.; Department of Clinical Sciences, Institute of Tropical Medicine, Kronenburgstraat 43, 2000, Antwerpen, Belgium.; Department of Family Medicine and Population Health, University of Antwerp, Doornstraat 331 2610, Antwerpen, Belgium.
Homan T; Médecins Sans Frontières, No 5/59, Ayeyadanar Street, Thirigon Villa, Waizayandar Road, Thingangyun Township, 11071, Yangon, Myanmar.
Lenglet A; Médecins Sans Frontières, Public Health Department, Plantage Middenlaan 14, 1001DD, Amsterdam, The Netherlands.; Department of Medical Microbiology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
Thit P; Médecins Sans Frontières, No 5/59, Ayeyadanar Street, Thirigon Villa, Waizayandar Road, Thingangyun Township, 11071, Yangon, Myanmar.
Mar HT; Médecins Sans Frontières, No 5/59, Ayeyadanar Street, Thirigon Villa, Waizayandar Road, Thingangyun Township, 11071, Yangon, Myanmar.
Sabai SM; Médecins Sans Frontières, No 5/59, Ayeyadanar Street, Thirigon Villa, Waizayandar Road, Thingangyun Township, 11071, Yangon, Myanmar.
Thandar MP; Médecins Sans Frontières, No 5/59, Ayeyadanar Street, Thirigon Villa, Waizayandar Road, Thingangyun Township, 11071, Yangon, Myanmar.
Thwe TT; Médecins Sans Frontières, No 5/59, Ayeyadanar Street, Thirigon Villa, Waizayandar Road, Thingangyun Township, 11071, Yangon, Myanmar.
Kyaw AA; Médecins Sans Frontières, No 5/59, Ayeyadanar Street, Thirigon Villa, Waizayandar Road, Thingangyun Township, 11071, Yangon, Myanmar.
Decroo T; Department of Clinical Sciences, Institute of Tropical Medicine, Kronenburgstraat 43, 2000, Antwerpen, Belgium.; Research Foundation Flanders, Egmontstraat 5, 1000, Brussels, Belgium.
Spina A; University of Exeter Medical School, Heavitree Road, Exeter EX1 2LU, UK.
Ariti C; Centre for Trials Research, Cardiff University Medical School, Heath Park Cardiff, CF14 4XN, Cardiff, UK.
Ritmeijer K; Médecins Sans Frontières, Public Health Department, Plantage Middenlaan 14, 1001DD, Amsterdam, The Netherlands.
Van Olmen J; Department of Clinical Sciences, Institute of Tropical Medicine, Kronenburgstraat 43, 2000, Antwerpen, Belgium.; Department of Family Medicine and Population Health, University of Antwerp, Doornstraat 331 2610, Antwerpen, Belgium.
Oo HN; Ministry of Health and Sports, National AIDS Programme, Office No. 47, 15011, Nay Pyi Taw, Myanmar.
Lynen L; Department of Family Medicine and Population Health, University of Antwerp, Doornstraat 331 2610, Antwerpen, Belgium.

Pokaż więcej

Źródło:

International health [Int Health] 2023 Jul 04; Vol. 15 (4), pp. 453-461.

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Retrospective Studies ; Myanmar/epidemiology ; CD4 Lymphocyte Count ; Risk Factors

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 44.

Tytuł:

The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure.

Autorzy:

Mortezazadeh M; Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Kalantari S; Department of Infectious Disease, Antimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
Abolghasemi N; Department of Pharmacology, Islamic Azad University Pharmaceutical Sciences Branch -Pharmacy School, Tehran, Iran.
Ranjbar M; Department of Infectious Disease, Firoozgar General Hospital, Iran University of Medical Sciences, Tehran, Iran.
Ebrahimi S; Department of Infectious Disease, Alborz University of Medical Sciences, Karaj, Iran.
Mofidi A; Department of Infectious Disease, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Pezeshkpour B; Department of Infectious Disease, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mansouri ES; Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Tabatabaei SZ; Internal Medicine Department, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Kashani M; Department of Infectious Disease, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Pokaż więcej

Źródło:

Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Jun; Vol. 11 (6), pp. e913.

Typ publikacji:

Randomized Controlled Trial; Journal Article

MeSH Terms:

HIV Infections*/drug therapy
Probiotics*/therapeutic use
Humans ; CD4 Lymphocyte Count ; Flow Cytometry ; Inflammation

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 45.

Tytuł:

State-of-the-Art Molecular Oncology in Brazil.

Autorzy:

Rodrigues T; Centro de Ciências Naturais e Humanas (CCNH), Universidade Federal do ABC (UFABC), Santo André 09210-580, Brazil.

Pokaż więcej

Źródło:

International journal of molecular sciences [Int J Mol Sci] 2023 May 29; Vol. 24 (11). Date of Electronic Publication: 2023 May 29.

Typ publikacji:

Editorial

MeSH Terms:

HIV Infections*
Humans ; Brazil/epidemiology ; Life Expectancy ; CD4 Lymphocyte Count

Opinia redakcyjna

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 46.

Tytuł:

Trends and factors associated with initiation of HIV treatment among PLHIV in Jamaica, 2015-2019.

Autorzy:

Cushnie A; Faculty of Social Sciences, Unit of Health Sciences, Tampere University, Tampere, Finland.
Reintjes R; Faculty of Social Sciences, Unit of Health Sciences, Tampere University, Tampere, Finland.; Department of Health Sciences, Hamburg University of Applied Sciences, Hamburg, Germany.
Figueroa JP; Department of Community Health and Psychiatry, University of the West Indies, Mona, Jamaica.
Artama M; Faculty of Social Sciences, Unit of Health Sciences, Tampere University, Tampere, Finland.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 May 26; Vol. 18 (5), pp. e0265468. Date of Electronic Publication: 2023 May 26 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/diagnosis
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Jamaica/epidemiology ; Delayed Diagnosis ; Logistic Models ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 47.

Tytuł:

Characterization of oral candidiasis according to antiretroviral treatment status, immunological and virological profiles among HIV infected patients in two health facilities in Yaoundé-Cameroon: a cross-sectional and analytical study.

Autorzy:

Fokam J; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.; Faculty of Health Science, University of Buea, Buea, Cameroon.; Ministry of Public Health, National HIV Drug Resistance Working Group, Yaoundé, Cameroon.
Nka AD; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.; Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy.; Faculty of Sciences and Technology, Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon.
Semengue ENJ; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.; Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy.; Faculty of Sciences and Technology, Evangelical University of Cameroon, Mbouo-Bandjoun, Cameroon.
Asso'o CKE; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Gabisa JE; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Ka'e AC; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.; Faculty of Medicine and Surgery, University of Rome 'Tor Vergata', Rome, Italy.
Bouba Y; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Pabo W; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.; Faculty of Science, University of Buea, Buea, Cameroon.
Geh BKN; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Gouissi D; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Chenwi CA; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Tchouaket MCT; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.; School of Health Sciences, Catholic University of Central Africa, Yaoundé, Cameroon.
Abba A; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Takou D; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Fainguem N; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Kamgaing RS; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Sosso SM; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.
Abena MEN; Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Ndjolo A; Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB), Yaoundé, Cameroon.

Pokaż więcej

Źródło:

The Pan African medical journal [Pan Afr Med J] 2023 May 15; Vol. 45, pp. 33. Date of Electronic Publication: 2023 May 15 (Print Publication: 2023).

Typ publikacji:

Journal Article

MeSH Terms:

Candidiasis, Oral*/epidemiology
Candidiasis, Oral*/drug therapy
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Candidiasis*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Cross-Sectional Studies ; Cameroon/epidemiology ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Viral Load

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknieSzczegóły

Skocz do pozycji: 48.

Tytuł:

Six months survival and risk factors for attrition for patients detected with cryptococcal antigenemia through screening in Malawi.

Autorzy:

Chisale MRO; Ministry of Health, Malawi, Mzuzu Central Hospital, Luwinga, Mzuzu, Malawi.; College of Medicine, University of Malawi, Zomba, Malawi.; Faculty of Science Technology and Innovations, Biological Sciences Department, Mzuzu University, Mzuzu, Malawi.
Jordan A; Centres for Disease Control and Prevention, Mycotic Diseases Branch, Atlanta, GA, United States of America.
Kamudumuli PS; University of Maryland Global Initiative Corporation (UMGIC), Lilongwe, Malawi.
Mvula B; Ministry of Health, National HIV Unit laboratory, Lilongwe, Malawi.
Odo M; Ministry of Health, Department of HIV and AIDS (DHA), Lilongwe, Malawi.
Maida A; Centres for Disease Control and Prevention-Malawi, Malawi.
Kandulu J; Capitol Hill (Headquarters), Ministry of Health, Ministry of Health, Lilongwe, Malawi.
Chilima B; Public Health Institute of Malawi (PHIM), Ministry of Health, Lilongwe, Malawi.
Sinyiza FW; Ministry of Health, Malawi, Mzuzu Central Hospital, Luwinga, Mzuzu, Malawi.
Katundu P; Public Health Institute of Malawi (PHIM), Ministry of Health, Lilongwe, Malawi.
Lee HY; College of Medicine, University of Malawi, Zomba, Malawi.
Mtegha R; College of Medicine, University of Malawi, Zomba, Malawi.
Wu TJ; College of Medicine, University of Malawi, Zomba, Malawi.; Luke International, Mzuzu, Malawi.
Bitirinyo J; Public Health Institute of Malawi (PHIM), Ministry of Health, Lilongwe, Malawi.
Nyirenda R; Ministry of Health, Department of HIV and AIDS (DHA), Lilongwe, Malawi.
Kalua T; University of Maryland Global Initiative Corporation (UMGIC), Lilongwe, Malawi.
Greene G; Centres for Disease Control and Prevention, Mycotic Diseases Branch, Atlanta, GA, United States of America.
Chiller T; Centres for Disease Control and Prevention, Mycotic Diseases Branch, Atlanta, GA, United States of America.

Pokaż więcej

Źródło:

PloS one [PLoS One] 2023 May 04; Vol. 18 (5), pp. e0284367. Date of Electronic Publication: 2023 May 04 (Print Publication: 2023).

Typ publikacji:

Journal Article; Research Support, Non-U.S. Gov't

MeSH Terms:

Cryptococcus*
Meningitis, Cryptococcal*/diagnosis
Meningitis, Cryptococcal*/epidemiology
HIV Infections*/complications
HIV Infections*/epidemiology
HIV Infections*/drug therapy
Adult ; Humans ; Malawi/epidemiology ; Antigens, Fungal ; Risk Factors ; CD4 Lymphocyte Count

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 49.

Tytuł:

Effect of characteristics on the clinical course at the initiation of treatment for human immunodeficiency virus infection using dimensionality reduction.

Autorzy:

Choi, Yunsu (AUTHOR)
Choi, Bo Youl (AUTHOR)
Kim, Sang Il (AUTHOR)
Choi, Jungsoon (AUTHOR)
Kim, Jieun (AUTHOR)
Park, Bo Young (AUTHOR)
Kim, Soo Min (AUTHOR)
Kim, Shin-Woo (AUTHOR)
Choi, Jun Yong (AUTHOR)
Song, Joon Young (AUTHOR)
Kim, Youn Jeong (AUTHOR)
Kim, Hyo Youl (AUTHOR)
Lee, Jin-Soo (AUTHOR)
Kim, Jung Ho (AUTHOR)
Jun, Yoon Hee (AUTHOR)
Lee, Myungsun (AUTHOR)
Seong, Jaehyun (AUTHOR)

Pokaż więcej

Źródło:

Scientific Reports. 4/4/2023, Vol. 13 Issue 1, p1-8. 8p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły

Skocz do pozycji: 50.

Tytuł:

Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART.

Autorzy:

Pantazis, Nikos (AUTHOR)
Paparizos, Vasilios (AUTHOR)
Papastamopoulos, Vasilios (AUTHOR)
Metallidis, Simeon (AUTHOR)
Antoniadou, Anastasia (AUTHOR)
Adamis, Georgios (AUTHOR)
Psichgiou, Mina (AUTHOR)
Chini, Maria (AUTHOR)
Sambatakou, Helen (AUTHOR)
Chrysos, Georgios (AUTHOR)
Sipsas, Nikolaos V. (AUTHOR)
Gogos, Charalambos (AUTHOR)
Barbunakis, Emmanouil (AUTHOR)
Panagopoulos, Periklis (AUTHOR)
Katsarou, Olga (AUTHOR)
Touloumi, Giota (AUTHOR)

Pokaż więcej

Źródło:

PLoS ONE. 3/30/2023, Vol. 17 Issue 3, p1-16. 16p.

Czasopismo naukowe

• na półce

Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły